|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0752 SEK | -5.41% |
|
-13.96% | -78.70% |
| Apr. 05 | Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic | CI |
| Apr. 05 | Diagonal Bio AB Announces Successful Pilot Study Results | CI |
Diagonal Bio AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 1.03 million compared to SEK 0.583 million a year ago. Revenue was SEK 1.04 million compared to SEK 0.597 million a year ago.
Net loss was SEK 3.69 million compared to SEK 3.38 million a year ago. Basic loss per share from continuing operations was SEK 0.11 compared to SEK 0.37 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -78.70% | 2.75M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
DIAGONAL BIO AB 
